Procept (PRCT): 50% rise on high volume. Why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?

PRCT 30.67

-2.1%

1:41 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gerald Thomas who wrote (82)	4/8/1997 12:56:00 PM
From: Douglas	of 455

The only positive mentioned in the 10K was that no side-effects were observed from administering the drug intravenously. The number of patients in this study was only eight. Not a large number. My personal guess(pure speculation) would be that the postponement(indefinitely) was for the following reasons: 1. Their results were not any better than what's all ready available for the treatment of AIDS. Nothing different. 2. Lack of cash. 3. Survival is greatest with clinical development of PRO 2000. Funding possibilities are greater. 4. Quicker development of the PRO 2000 gel. Hopefully, we will have a press release sometime soon! I tried to send an e-mail to Procept at webmaster@procept.com ,but no delivery. Please send me the e-mail address you have. Thanks.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next